In the journals: Acupuncture relieves common types of chronic pain

Acupuncture relieves chronic pain in the back, neck, and shoulders, and from osteoarthritis and headaches. Acupuncture is often used in addition to standard treatments, such as pain medications, when they do not relieve pain well enough.

Content restricted. Requires subscription

In the journals: Most people don’t take heart drugs as directed

Most people do not fill their prescriptions for heart medications as directed. Unfilled prescriptions include those fop aspirin, ACE inhibitors, angiotensin receptor blockers, beta blockers, calcium-channel blockers, thiazide diuretics, and statins.

Content restricted. Requires subscription

Study: More Sleep May Aid Kids’ Behavior

Kids who get even a little more sleep may behave better in school, a small new study suggests. The study included 34 kids, ages 7 to 11. They did not have sleep disorders. They got an average of 9 hours of sleep a night. They also had no problems with mental health or learning. Children were randomly divided into 2 groups. One group went to bed an hour earlier than usual for 5 days in a row. The other group stayed up an hour later than usual for 5 days. On average, the first group got about one-half hour of extra sleep daily. The second group got about an hour less. Before the study, teachers answered questions about each child’s mood and behavior in class. After the study, they answered the same questions. Teachers ranked the kids in the sleep-deprived group as more restless, impulsive and moody than they were before the study.

Content restricted. Requires subscription

More Problems after Fast Drug Approvals

A new study adds to the evidence that serious side effects of new drugs often show up later. It also shows that drugs approved through a fast-track process may be more likely to have problems. The study looked recent drug approvals in Canada and what was learned about the drugs after approval. Researchers focused on 434 drugs. They were approved between 1995 and 2010. Most drugs went through a 300-day standard approval process. About 1 out of 4 went through a 180-day process. The fast process is used if a condition has no good treatments, or if the new drug may offer a major advantage over current treatments. Of the drugs that went through the standard process, one-fifth became the subject of a serious safety warning or were withdrawn from the market. These problems occurred for about one-third of drugs that went through the fast approval process.

Content restricted. Requires subscription